Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 89134448

VSX2 Sheep anti-Human, Mouse, Rat, Polyclonal Antibody, Abnova™

Catalog No. 89134448 Shop All Abnova Corporation Products
Change view
Click to view available options
Quantity:
250 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
89-134-448 250 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 89-134-448 Supplier Abnova Corporation Supplier No. PAB9843
Add to Cart
Add to Cart

Description

Sheep polyclonal antibody raised against partial recombinant VSX2.

Specifications

Antigen VSX2
Applications Immunohistochemistry (Frozen), Western Blot
Classification Polyclonal
Conjugate Unconjugated
Description Sheep polyclonal antibody raised against partial recombinant VSX2.
Dilution Western Blot (0.5-1.0 ug/mL) The optimal working dilution should be determined by the end user.
Formulation In PBS (0.08% sodium azide)
Gene VSX2
Gene Alias CHX10/HOX10/MCOP2/MCOPCB3/RET1
Gene Symbols VSX2
Host Species Sheep
Immunogen Recombinant GST fusion protein corresponding to amino acids 1-131 of human VSX2.
Quantity 250 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 338917
Target Species Human, Mouse, Rat
Content And Storage Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
Form Liquid
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.